Key Insights

Highlights

Treatment Research

2 treatments under study, led by Linac

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07132918Phase 2Recruiting

HEARTS Trial for Thoracic Cancers

Showing all 1 trials

Research Network

Common Treatments

  • Linac1
  • Mrgart1

Active Sponsors

  • University of Wisconsin, Madison1
  • National Heart, Lung, and Blood Institute (NHLBI)1

Top Investigators

Related Conditions

  • Esophagogastric Cancer Stage Iiii1
  • Nonsmall Cell Lung Cancer Stage Iii1
  • Other Cancers In The Thoracic Region1
  • Esophageal Cancer Stage Iiii1

Activity Timeline